dupilumab
IRB00229130
Phase 2 mab completed
Quick answer
dupilumab for Chronic Sinusitis is a Phase 2 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Chronic Sinusitis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed